NO20052251L - Nasalt anvendbart farmasoytisk preparat og fremstilling derav. - Google Patents

Nasalt anvendbart farmasoytisk preparat og fremstilling derav.

Info

Publication number
NO20052251L
NO20052251L NO20052251A NO20052251A NO20052251L NO 20052251 L NO20052251 L NO 20052251L NO 20052251 A NO20052251 A NO 20052251A NO 20052251 A NO20052251 A NO 20052251A NO 20052251 L NO20052251 L NO 20052251L
Authority
NO
Norway
Prior art keywords
composition
buffer
pharmaceutical composition
osmotic
preparation
Prior art date
Application number
NO20052251A
Other languages
English (en)
Inventor
Gerhard Hantich
Ernst Hesse
Helmut Scheidl
Wolfgang H Nitschmann
Original Assignee
Gebro Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gebro Pharma Gmbh filed Critical Gebro Pharma Gmbh
Publication of NO20052251L publication Critical patent/NO20052251L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er beskrevet et nytt nasalt anvendbart farmasøytisk preparat på basis av en vandig oppløsning, emulsjon eller lignende inneholdende minst et slimhinneresorberbart og/eller lokalt virkende farmasøytisk virkestoff, minst et ved benzalkoniumklorid alene eller sammen med andre konserveringsstoffer dannet konserveringsmiddel, minst en buffer som holder pH-verdien på 4 til 6 samt videre minst et osmotikum og/eller minst et fuktemiddel, kjennetegnet ved at det oppviser en vesentlig forbedret silietålbarhet ved at det under bibehold av de for det farmasøytiske preparatet i hvert tilfelle forutsette sammensetnings-, konsentrasjons- og mengdeforholdende av virksomt stoff (- stoffer), konserveringsmiddel (-midler), osmotikum (-a) og/eller fuktemiddel (-midler) i stedet for en i det farmasøytiske preparatet hittil anvendte buffer på basis av citrat(er), fosfat(er) og/eller acetat(er) - inneholder en buffer på basis av eplesyrer, som helt eller delvis erstatter denne.Det er likeledes beskrevet en fremgangsmåte for fremstilling av preparatet og anvendelse av en eplesyrebuffer i preparatet.
NO20052251A 2002-10-10 2005-05-09 Nasalt anvendbart farmasoytisk preparat og fremstilling derav. NO20052251L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0154002A AT413078B (de) 2002-10-10 2002-10-10 Verwendung eines puffers auf basis von apfelsäure für die herstellung einer nasal applizierbaren zubereitung
PCT/AT2003/000306 WO2004032896A1 (de) 2002-10-10 2003-10-09 Nasal applizierbare pharmazeutische zubereitung und deren herstellung

Publications (1)

Publication Number Publication Date
NO20052251L true NO20052251L (no) 2005-05-09

Family

ID=32074994

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052251A NO20052251L (no) 2002-10-10 2005-05-09 Nasalt anvendbart farmasoytisk preparat og fremstilling derav.

Country Status (9)

Country Link
US (1) US20060127317A1 (no)
EP (1) EP1549288A1 (no)
JP (1) JP2006503868A (no)
AT (1) AT413078B (no)
AU (1) AU2003266811A1 (no)
CA (1) CA2501760A1 (no)
NO (1) NO20052251L (no)
PL (1) PL375762A1 (no)
WO (1) WO2004032896A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007006122A1 (de) * 2007-02-02 2008-08-07 Krewel Meuselbach Gmbh Cistusextrakte
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
JP2016532660A (ja) * 2013-10-08 2016-10-20 イノファーマ インク アプレピタント経口液体製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung

Also Published As

Publication number Publication date
ATA15402002A (de) 2005-04-15
CA2501760A1 (en) 2004-04-22
AU2003266811A1 (en) 2004-05-04
WO2004032896A1 (de) 2004-04-22
PL375762A1 (en) 2005-12-12
US20060127317A1 (en) 2006-06-15
JP2006503868A (ja) 2006-02-02
EP1549288A1 (de) 2005-07-06
AT413078B (de) 2005-11-15

Similar Documents

Publication Publication Date Title
IN2001KO01049A (no)
CA2342856A1 (en) Stabilized two-part disinfecting system and compositions and methods related thereto
BRPI0311877B8 (pt) formulação farmacêutica ácida de insulina com estabilidade aperfeiçoada
CA2102693A1 (en) Protein formulation comprising growth hormone
NO20012661L (no) Fremgangsmåte for å redusere astringens av tinn(II) i dentifriciumsammensetninger
CA2397496A1 (en) Acidic antimicrobial compositions for treating food and food contact surfaces and methods of use thereof
WO2005115416A3 (en) Method of treating with chlorine dioxide
ATE384534T1 (de) Lösung zur nagel-verwendung
BR0112461A (pt) Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada
BR0116369A (pt) Composto, método para a profilaxia ou o tratamento de uma condição clìnica em um mamìfero, formulação farmacêutica, uso de um composto, e, processo para preparar composto
WO2005116081A3 (en) Stable protein storage and stable nucleic acid storage in recoverable form
CA2027483A1 (fr) Procede de preparation d'une solution aqueuse effervescente ayant une action emolliente sur la cuticule des ongles, composition pour la mise en oeuvre dudit procede et traitement cosmetique correspondant
WO2006039231A3 (en) Topical formulations for the treatment of depression with s adenosyl methionine
CA2391076A1 (en) Solutions containing epinastin
CA2256410A1 (en) Stable pharmaceutical composition of bdnf
CA2433558A1 (en) Dual component dentifrice for reducing mouth odors
DE602004015725D1 (de) Stabilisierte lyophilisierte zubereitungen mit gewebefaktor-inhibitor (tfpi) oder varianten des gewebefaktor-inhibitors
NO20052251L (no) Nasalt anvendbart farmasoytisk preparat og fremstilling derav.
CA2388056A1 (en) Method of stabilizing dye solutions and stabilized dye compositions
EP0985347A4 (en) EFFERVESCENT PREPARATION FOR PLANTS
KR930000096A (ko) 제제
RU2010126214A (ru) Косметическая композиция для ухода за волосами
MY136546A (en) A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component
CA2438622A1 (en) Compositions containing creatine and creatinine
IE821000L (en) Pharmaceutical compositions for treating nail infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application